Breaking News

Tweet TWEET

Benelux Stocks: ArcelorMittal, Draka, Omega Pharma, Ordina Move

The Amsterdam Exchange Index declined 7.60, or 2.2 percent, to 334.82 at 5:30 p.m. local closing time, a third straight decline. Belgium’s Bel20 Index retreated 59.10, or 2.2 percent, to 2,584.25.

The following are among the most active stocks in the Benelux markets today. Symbols are in parentheses.

Dutch stocks:

ArcelorMittal (MT NA), the world’s biggest steelmaker, fell 2.9 percent to 23.70 euros, following basic-resources stocks lower.

Draka Holding NV (DRAK NA) fell 1.7 percent to 19.27 euros, after Chief Executive Officer Frank Dorjee said the proposed combination with Prysmian SpA is “compelling,” and the “best fit” for the Dutch cable maker.

Holland Colours NV (HOLCO NA) surged 7.6 percent to 28.20 euros, the biggest gain since Aug. 6. SNS Securities raised its price estimate on the maker of red coloring for the wax coat on Edam cheese to 31 euros from 24 euros.

Belgian stocks:

Devgen NV (DEVG BB) advanced 2.5 percent to 5.76 euros, a third day of gains. Devgen board member Rudi Marien, whose Biovest CVA owns 11 percent of the Belgian developer of hybrid rice, sunflower and sorghum seeds, bought 1.1 million euros of the company’s stock.

Omega Pharma NV (OME BB) gained 0.9 percent to 32.55 euros, reversing two days of declines. Belgium’s largest supplier of pharmacy products was raised to “buy” from “hold” at Royal Bank of Scotland Group Plc.

Ordina NA (ORDI NA) fell 3.5 percent to 3.13 euros, the steepest decline in two months. RealDolmen NV, the Belgian computer-services firm created in a 2008 merger, is not in takeover or merger talks with Dutch rivals including Ordina and Qurius NV, Secretary General Thierry de Vries said. Qurius added 3.3 percent to 28.5 euro cents.

To contact the reporter on this story: Maud van Gaal in Amsterdam at mvangaal@bloomberg.net.

To contact the editor responsible for this story: Frank Connelly at fconnelly@bloomberg.net.

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.